Search results
Showing 2701 to 2750 of 3766 results for treatment
This quality standard covers prevention of falls and assessment after a fall in people who are living in the community, in a residential care setting or staying in hospital and are:
View quality statements for QS86Show all sections
Sections for QS86
- Quality statements
- Quality statement 1: Asking people about falls
- Quality statement 2: Comprehensive falls assessment
- Quality statement 3: Interventions to reduce the risk of falls
- Quality statement 4: Checks for injury after an inpatient fall
- Quality statement 5: Safe manual handling after an inpatient fall
- Quality statement 6: Medical examination after an inpatient fall
- Quality statement 7: Multifactorial risk assessment for older people presenting for medical attention
Vagus nerve stimulation for refractory epilepsy in children (IPG50)
Evidence-based recommendations on vagus nerve stimulation for refractory epilepsy in children. This involves placing a device under the skin to send a burst of nerve messages through the nerve.
View recommendations for IPG50Show all sections
Sections for IPG50
remains about the accuracy and consequent identification of appropriate treatment by paraprofessionals in primary care. An assessment by...
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care (HTG607)
Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.
notes(if applicable) Why this is important:- Epidural injection of treatments, including corticosteroids, is commonly offered to people...
This quality standard covers the assessment and early management of fever with no obvious cause in babies and children (from birth to 5 years). It describes high-quality care in priority areas for improvement.
important:- There is a lack of published evidence on care pathways on treatment, management and follow-up of people with coexisting...
efficacy of the procedure. Therefore, laparoscopic gastric plication for the treatment of severe obesity should only be used with...
Radiofrequency ablation for the treatment of colorectal metastases in the liver (IPG92)
This guidance has been updated and replaced by NICE interventional procedure guidance 327.
Non-rigid stabilisation techniques for the treatment of low back pain (IPG183)
This guidance has been updated and replaced by NICE interventional procedure guidance 366.
Beta interferon and glatiramer acetate for the treatment of multiple sclerosis (TA32)
This guidance has been updated and replaced by NICE technology appraisal guidance 527.
Medical technologies evaluation programme process guide (PMG34)
This process guide describes how NICE selects medical technologies for development of NICE guidance. It also describes how the medical technologies advisory committee develops guidance on selected technologies routed to it
Pre-hospital initiation of fluid replacement therapy in trauma (TA74)
Evidence-based recommendations on giving intravenous (IV) fluid replacement therapy for people with serious injuries before reaching hospital.
Evidence-based recommendations on combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD). This involves accessing the bones of the hip and pelvis through a cut made on the thigh and correcting the deformity as much as possible.
View recommendations for IPG297Show all sections
Sections for IPG297
Image-guided radiofrequency excision biopsy of breast lesions (IPG308)
Evidence-based recommendations on image-guided radiofrequency excision biopsy of breast lesions. This involves inserting a probe that uses radiofrequency energy to cut through the breast internally, and removing the lump with a small area of surrounding tissue to test for cancer.
View recommendations for IPG308Show all sections
Sections for IPG308
are still clinically and cost effective. Retaining more service users in treatment could further significantly improve outcomes for...
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)
NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes .
recognised, resulting in some people not being offered the most appropriate treatment. Research is needed to help healthcare...
concentration in treated children with FH receiving lipid-modifying drug therapy. Treatment is recommended from 10 years onwards,...
This guidance has been replaced by NICE technology appraisal guidance 98 [Replaced by NICE guideline NG87].
diagnosis for people who need enteral nutrition support during curative treatment. Variation across the UK exists as a result of...
is important:- Quality of life is the most important overall measure of treatment effect for patients as it measures their life...
impact of adenomyosis on symptoms of HMB or the best treatment for this condition. Optimising treatment can lead to better...
Telaprevir for the treatment of genotype 1 chronic hepatitis C (TA252)
Telaprevir no longer has a marketing authorisation in the UK so this guidance has been withdrawn.
Cetuximab for the first-line treatment of metastatic colorectal cancer (TA176)
This guidance has been updated and replaced by NICE technology appraisal guidance 439.
Erlotinib for the treatment of non-small-cell lung cancer (TA162)
This guidance has been updated and replaced by NICE technology appraisal guidance 374.
Bevacizumab for the first-line treatment of metastatic breast cancer (TA147)
This appraisal has been updated and replaced by NICE technology appraisal 214.
Human growth hormone for the treatment growth failure in children (TA42)
This guidance has been updated and replaced by NICE technology appraisal guidance 188.
PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)
We have moved Diagnostics guidance 45 to become HealthTech guidance 610. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)
We have moved medical technologies guidance 6 to become HealthTech guidance 268. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
at the end of this treatment period is important, since some people remain at high risk of fracture and require continued...
morbidity and mortality. As a result, NASH has been the main target for treatment in NAFLD. This is because reducing the severity of...
Evidence-based recommendations on intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure in people with motor neurone disease. This involves implanting electrodes into the diaphragm to make it contract. This gradually strengthens the diaphragm and may eventually help the person to breathe without a ventilator.
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence.
Evidence-based recommendations on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. This involves placing a device under the skin of the chest, which detects and treats fast heartbeats called tachyarrhythmias.
Assessing motility of the gastrointestinal tract using a wireless capsule (IPG502)
Evidence-based recommendations on assessing motility of the gastrointestinal tract using a wireless capsule. This involves swallowing a capsule that sends bowel information as it passes through the digestive system.
Laparoscopic mobilisation of the greater omentum for breast reconstruction (IPG253)
Evidence-based recommendations on laparoscopic mobilisation of the greater omentum for breast reconstruction. This involves removing the fatty tissue using special instruments through small cuts in the abdomen.
View recommendations for IPG253Show all sections
Sections for IPG253
basis for needs assessment and decisions about therapeutic interventions, treatment placements and care plans.For those in the criminal...
How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period?
explanatory notes(if applicable) Drugs are effective for the acute treatment of bipolar disorder and for preventing relapse. All drugs...
diagnose non‑bladder injuries. People who do not have injuries needing urgent treatment may then either be given another CT scan or a...
Laparoscopic prostatectomy for benign prostatic obstruction (IPG275)
Evidence-based recommendations on laparoscopic prostatectomy for benign prostatic obstruction. This involves removing the prostate through small cuts in the abdomen, using a fine telescope to see inside the body (keyhole surgery).
View recommendations for IPG275Show all sections
Sections for IPG275
Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula (IPG507)
Evidence-based recommendations on insertion of a collagen plug to close an abdominal wall enterocutaneous fistula. This involves inserting a collagen plug into the fistula to seal off where it joins the bowel.
NICE has developed a medtech innovation briefing (MIB) on cyanoacrylate glue for hernia mesh fixation .
diagnose non-bladder injuries. People who do not have injuries needing urgent treatment may then either be given another CT scan or a...
endovascular treatment. Infra-geniculate disease is more complex to treat by endovascular means, and the risks and benefits of different...
them. During the consent process, patients should be told about all treatment options, and their advantages and disadvantages. ViV‑TAVI...
Guidance on the use of gemcitabine for the treatment of pancreatic cancer (TA25)
This guidance has been replaced by NICE guideline NG85.
Computerised cognitive behaviour therapy (CCBT) for the treatment of depression and anxiety (TA51)
This guidance has been updated and replaced by NICE technology appraisal guidance 97.
This guidance has been replaced by NICE technology appraisal guidance 317.